Definitive endoderm

Details for Australian Patent Application No. 2004309421 (hide)

Owner ViaCyte, Inc

Inventors D'Amour, Kevin Allen; Agulnick, Alan D.; Baetge, Emmanuel E.

Agent Freehills

Pub. Number AU-B-2004309421

PCT Pub. Number WO2005/063971

Priority 60/532,004 23.12.03 US; 60/587,942 14.07.04 US; 60/586,566 09.07.04 US

Filing date 23 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 21 April 2011

International Classifications

C12N 5/073 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Embryonic cells or tissues

C12N 5/0735 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Embryonic stem cells

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063971 Priority application(s): WO2005/063971

24 March 2011 Alteration of Name

  The name of the applicant has been altered to ViaCyte, Inc. 2005

21 April 2011 Application Accepted

  Published as AU-B-2004309421

11 August 2011 Opposition Lodged

  Geron Corporation has lodged an opposition against ViaCyte, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309424-A method of prioritising a sample

2004309420-Bicyclic heterocyclic p-38 kinase inhibitors